Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
anaplastic, arm, Asia, asset, AU, beracizumab, carrying, Code, committee, constituted, cooling, copy, disruptive, distributor, doubling, EMEA, Eric, Error, EUR, extinguishment, extraordinary, Fairly, FAS, FSP, GAAP, Genetech, genome, glioblastoma, glioma, intangible, Intermittent, issuer, kilogram, Latin, leucovirin, lymphopenia, MAA, multiforme, nongovernmental, ordinary, orVelocImmune, ourVelociGene®orVelocImmune, ourVelociGene®technology, ourVelocImmune®human, ourVelocImmune®license, ourVelocImmune®technology, Oversight, oxaliplatin, Pacific, premium, published, RECIST, reconcile, reconciled, redemption, relapsed, renewal, repeat, repurchase, repurchased, Shooter, stimuli, Subscription, theVelocImmune, transition, transitioning, unknown, unpaid, women
Removed:
adenocarcinoma, arrange, blinded, compare, continuing, Countering, death, episode, eventually, feature, inhibiting, Macugen, mild, mutation, NSCLA, Orphan, oxygen, preexisting, promoting, provoke, refinance, refinancing, registration, regression, remove, resulted, stimulate, temperature, vessel, waste
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 4.1 EX-4.1: Form of Certificate of Shares of Common Stock
- 10.2 EX-10.2: Amended and Restated Non-exclusive License Agreement
- 10.3 EX-10.3: Subscription Agreement
- 12.1 EX-12.1: Statement Re: Computation of Ratio of Earnings
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32 EX-32: Certification
Related press release
REGN similar filings
Filing view
External links